Profile data is unavailable for this security.
About the company
Medipal Holdings Corp is a Japan-based company principally engaged in the wholesale of pharmaceuticals, cosmetics, daily necessities, and veterinary medicines. The Company operates in three segments. The Prescription Pharmaceuticals Wholesale Business segment engages in wholesale business targeting customers such as hospitals, clinics, and dispensing pharmacies. The Cosmetics, Daily Necessities, and General Pharmaceuticals Wholesale Business segment engages in wholesale business targeting customers such as drugstores, home improvement centers, convenience stores, and supermarkets. The Veterinary Medicines and Food Processing Raw Materials Wholesale Business segment engages in wholesale business targeting customers such as veterinary hospitals, livestock and fisheries producers, and processed food manufacturers. The Company also engages in preventive medicine, research and development of cutting-edge medical technology, non-life insurance agency services, and others.
- Revenue in JPY (TTM)3.74tn
- Net income in JPY40.64bn
- Incorporated1923
- Employees13.06k
- LocationMedipal Holdings Corp3-1-1, KyobashiCHUO-KU 104-8461JapanJPN
- Phone+81 335175800
- Fax+81 335175028
- Websitehttps://www.medipal.co.jp
| Holder | Shares | % Held |
|---|---|---|
| Silchester International Investors LLPas of 31 Mar 2025 | 11.12m | 5.15% |
| Nomura Asset Management Co., Ltd.as of 08 Jan 2026 | 7.69m | 3.56% |
| The Vanguard Group, Inc.as of 07 Jan 2026 | 6.76m | 3.13% |
| Schroder Investment Management Ltd.as of 30 Nov 2025 | 4.92m | 2.28% |
| Morant Wright Management Ltd.as of 30 Nov 2025 | 3.70m | 1.71% |
| Amova Asset Management Co., Ltd.as of 09 Jan 2026 | 3.46m | 1.60% |
| Daiwa Asset Management Co. Ltd.as of 30 Dec 2025 | 3.39m | 1.57% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 3.27m | 1.51% |
| Columbia Management Investment Advisers LLCas of 31 Dec 2025 | 2.60m | 1.20% |
| Brandes Investment Partners LPas of 29 Jan 2026 | 2.52m | 1.17% |
